Reading this on Krawl? Register for free.
Unlock listen-aloud, reading history and personalised feeds — at zero cost.
Free registration unlocks the full Finance Desk
HKIC renews CEO mandate as $7.9B state fund targets frontier industries
Hong Kong Investment Corporation has extended CEO Clara Chan's tenure through October 2029, aligning the $7.9 billion state-backed fund with Hong Kong's inaugural five-year plan. The plan directs patient capital toward frontier technology, biotech,…
Leadership continuity at a state fund in transition
Clara Chan Ka-chai will remain at the helm of Hong Kong Investment Corporation through October 2029, the wholly government-owned vehicle announced Friday. HKIC manages HK$62 billion — converted at current rates, approximately $7.9 billion — across four sub-funds covering hard technology, biotech, and new energy.
Financial Secretary and HKIC board chairman Paul Chan Mo-po framed the reappointment in terms of sectoral priorities. "I look forward to Clara's continued leadership of the HKIC over the next three years, contributing to the growth of Hong Kong's financial sector, innovation and technology sector and emerging industries, while supporting the development of the Northern Metropolis and the Guangdong-Hong Kong-Macau Greater Bay Area," he said.
Chan, appointed HKIC's founding CEO in 2023, said the fund would continue "harnessing the power of patient capital to support Hong Kong's long-term development." In a separate statement, she added: "I firmly believe that amidst this pivotal window of strategic development of Hong Kong, the HKIC could play our part in leveraging Hong Kong's strengths to serve the national needs, contributing to the high-quality development of Hong Kong and our country."
Five-year plan sets the capital deployment agenda
The tenure extension is directly timed to Hong Kong's first five-year plan, unveiled by Chief Executive John Lee Ka-chiu in mid-September. That plan commits to doubling innovation spending and explicitly directs patient capital — alongside other government funding mechanisms — into frontier industries and technology development. HKIC sits at the center of that directive.
The fund's initial HK$62 billion is split across the Hong Kong Growth Portfolio, the Greater Bay Area Investment Fund, the Strategic Tech Fund, and the Co-Investment Fund. As of September, HKIC had deployed capital into more than 200 projects since inception — including Beijing-based humanoid robotics startup Galbot, AI-driven drug developer Insilico Medicine, and sustainable aviation fuel producer EcoCeres.
Eleven portfolio companies have already listed on the Hong Kong Stock Exchange; 30 more have applied or are planning to apply for listings this year, Chan said at an earlier public event.
Performance metrics and the Temasek comparison
HKIC's second annual report, released in July, offered the fund's most detailed performance disclosure to date. Operating profit rose 181% year on year to HK$6.3 billion in 2025, and total assets expanded 9% to HK$69.7 billion over the same period. The net internal rate of return — disclosed publicly for the first time — came in at 14%.
The fund's capital mobilization record is the metric its backers emphasize most: for every Hong Kong dollar HKIC has committed, it has attracted more than HK$8 from global institutional investors, including sovereign funds, pension funds, family offices, and university endowments. That multiplier frames HKIC's core argument for its own existence — a state-seeded vehicle designed to draw international capital into sectors the private market was underweighting.
Observers have drawn a consistent comparison to Singapore's Temasek Holdings, a parallel HKIC itself has not discouraged. Whether the fund sustains a 14% net IRR as its portfolio matures — and as the frontier sectors it targets absorb more capital — is the durability question the next three years under Chan will begin to answer.
Found this useful? Share it!
Interested in Finance Education?
Explore our CFA and investing courses — built for serious learners.
